Skip to Main Content

Advertisement

Skip Nav Destination

Abstract A46: Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN)

Mol Cancer Ther (2015) 14 (7_Supplement): A46.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Hannah Zaryouh
  • Ines De Pauw
  • Hasan Baysal
  • Marc Peeters
  • Jan Baptist Vermorken
  • Filip Lardon
  • An Wouters
Medicinal Research Reviews (2022) 42 (1): 112.
  • Else Driehuis
  • Sigrid Kolders
  • Sacha Spelier
  • Kadi Lõhmussaar
  • Stefan M. Willems
  • Lot A. Devriese
  • Remco de Bree
  • Emma J. de Ruiter
  • Jeroen Korving
  • Harry Begthel
  • Johan H. van Es
  • Veerle Geurts
  • Gui-Wei He
  • Richard H. van Jaarsveld
  • Rurika Oka
  • Mauro J. Muraro
  • Judith Vivié
  • Maurice M.J.M. Zandvliet
  • Antoni P.A. Hendrickx
  • Nino Iakobachvili
  • Priya Sridevi
  • Onno Kranenburg
  • Ruben van Boxtel
  • Geert J.P.L. Kops
  • David A. Tuveson
  • Peter J. Peters
  • Alexander van Oudenaarden
  • Hans Clevers
Cancer Discovery (2019) 9 (7): 852.
Close Modal

or Create an Account

Close Modal
Close Modal